Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Quest Diagnostics Q1 2024 Adj EPS $2.04 Beats $1.86 Estimate, Sales $2.366B Beat $2.287B Estimate

Author: Benzinga Newsdesk | April 23, 2024 06:46am
Quest Diagnostics (NYSE:DGX) reported quarterly earnings of $2.04 per share which beat the analyst consensus estimate of $1.86 by 9.68 percent. This is unchanged from the same period last year. The company reported quarterly sales of $2.366 billion which beat the analyst consensus estimate of $2.287 billion by 3.46 percent. This is a 1.50 percent increase over sales of $2.331 billion the same period last year.

Posted In: DGX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist